Characterization of gene rearrangements resulted from genomic structural aberrations in human esophageal squamous cell carcinoma KYSE150 cells

Gene

Volumn 513, Issue 1, 2013, Pages 196-201

  Hao, Jia Jie ^a   Gong, Ting ^b   Zhang, Yu ^a   Shi, Zhi Zhou ^a   Xu, Xin ^a   Dong, Jin Tang ^c   Zhan, Qi Min ^a   Fu, Song Bin ^b   Wang, Ming Rong ^a  

^a CANCER HOSPITAL   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breakpoints; Disrupted genes; Esophageal cancer

Indexed keywords

ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME WALKING; COMPARATIVE GENOMIC HYBRIDIZATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DISRUPTION; GENE DOSAGE; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 9; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; SEQUENCE ANALYSIS, DNA; UBIQUITIN-PROTEIN LIGASES;

EID: 84872373837     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.091     Document Type: Article

References (36)

1. Calasanz M.J., Cigudosa J.C. Molecular cytogenetics in translational oncology: when chromosomes meet genomics. Clin. Transl. Oncol. 2008, 10:20-29.
2. Du X.L., et al. Proteomic profiling of proteins dysregulated in Chinese esophageal squamous cell carcinoma. J. Mol. Med. (Berl.) 2007, 85:863-875.
3. Fang M.Z., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63:7563-7570.
4. Ha K.C., et al. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines. BMC Med. Genomics 2011, 4:75.
5. Hou Z., et al. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 2005, 65:8049-8056.
6. Italiano A., et al. Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplification including JAK2 and JMJD2C. Cancer Genet Cytogenet 2006, 167:122-130.
7. Kandulski A., et al. Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am. J. Gastroenterol. 2010, 105:1934-1943.
8. Kohno T., et al. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 2010, 49:342-352.
9. Koivunen J.P., et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin. Cancer Res. 2008, 14:4275-4283.
10. Komatsu S., et al. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis 2009, 30:1139-1146.
11. Lambros M.B., et al. High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform. Lab. Invest. 2011, 91:1491-1501.
12. Liu G., et al. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 2009, 28:4491-4500.
13. Meng X.Y., et al. Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma. Dis. Esophagus 2011, 24:444-449.
14. Mertz K.D., et al. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Neoplasia 2007, 9:200-206.
15. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
16. Neve R.M., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527.
17. Okumura T., et al. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma. Clin. Cancer Res. 2006, 12:5096-5103.
18. Pan H.W., et al. Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle 2006, 5:2676-2687.
19. Pimkhaokham A., et al. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn. J. Cancer Res. 2000, 91:1126-1133.
20. Purdie K.J., et al. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 2007, 46:661-669.
21. Roukos V., et al. Dynamic recruitment of licensing factor Cdt1 to sites of DNA damage. J. Cell Sci. 2011, 124:422-434.
22. Sansam C.L., et al. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev. 2006, 20:3117-3129.
23. Sato M., et al. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer 2005, 44:405-414.
24. Shibata E., et al. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex. Mol. Cell. Biol. 2011, 31:3136-3145.
25. Song B., et al. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol. Cancer 2010, 9:96.
26. Stallings R.L., et al. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res. 2006, 66:3673-3680.
27. Stephens P.J., et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010.
28. Terai K., et al. CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Mol. Cell 2010, 37:143-149.
29. Tomlins S.A., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007, 448:595-599.
30. Ueki T., et al. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 2008, 27:5672-5683.
31. van Gent D.C., van der Burg M. Non-homologous end-joining, a sticky affair. Oncogene 2007, 26:7731-7740.
32. Veeriah S., et al. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9435-9440.
33. Wang X.C., et al. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma. Mol. Cancer Res. 2009, 7:12-22.
34. Yang Z.Q., et al. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 2000, 60:4735-4739.
35. Yang Z.Q., et al. A novel amplicon at 9p23-24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB. Jpn. J. Cancer Res. 2001, 92:423-428.
36. Zhu M.C., et al. Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer. Int. J. Colorectal Dis. 2012, 27:31-36.